CSIMarket Company Name, Ticker, Industry, else..


Tarsus Pharmaceuticals Inc   (NASDAQ: TARS)
Other Ticker:  
 

Tarsus Pharmaceuticals Inc

TARS's Fundamental analysis



Looking into Tarsus Pharmaceuticals Inc growth rates, revenue grew by 2471.78 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 166

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Tarsus Pharmaceuticals Inc net loss decreased from $-39 millions, to $-23 millions in III. Quarter 2024,

• More on TARS's Growth


Tarsus Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Tarsus Pharmaceuticals Inc realized cash reduction of $ -1.31 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 15.16.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.44.


• More on TARS's Valuation
 
 Total Debt (Millions $) 72
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 5,184,840
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.93
 Tangible Book Value (Per Share $) 5.96

Tarsus Pharmaceuticals Inc
realized net loss in trailing twelve months.

Tarsus Pharmaceuticals Inc realized cash outflow of $ -1.31per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 15.16.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.44.

Tarsus Pharmaceuticals Inc Price to Book Ratio is at 8.27 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01

• More on TARS's Valuation

•  Market Capitalization (Millions $) 1,965
•  Shares Outstanding (Millions) 38
•  Employees 25
•  Revenues (TTM) (Millions $) 130
•  Net Income (TTM) (Millions $) -134
•  Cash Flow (TTM) (Millions $) -50
•  Capital Exp. (TTM) (Millions $) -2
•  Total Debt (Millions $) 72
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 5,184,840
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4.93
•  Tangible Book Value (Per Share $) 5.96

•  Market Capitalization (Millions $) 1,965
•  Shares Outstanding (Millions) 38
•  Employees 25
•  Revenues (TTM) (Millions $) 130
•  Net Income (TTM) (Millions $) -134
•  Cash Flow (TTM) (Millions $) -50
•  Capital Exp. (TTM) (Millions $) -2





  Ratio
•   Capital Ratio (MRQ) 5.42
•  Total Debt to Equity (MRQ) 0.3
•  Tangible Leverage Ratio (MRQ) 0.61
•  Asset Turnover Ratio (TTM) 0.38
•  Inventory Turnover Ratio (TTM) 2.99





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com